Maj Invest Holding A S Cuts Stock Position in Cigna Group $CI

Maj Invest Holding A S lowered its stake in Cigna Group (NYSE:CI) by 13.4% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 412,686 shares of the health services provider’s stock after selling 63,783 shares during the quarter. Cigna Group accounts for about 4.8% of Maj Invest Holding A S’s portfolio, making the stock its 11th biggest holding. Maj Invest Holding A S’s holdings in Cigna Group were worth $136,424,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CI. Valeo Financial Advisors LLC increased its stake in shares of Cigna Group by 86,071.1% during the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Nuveen LLC acquired a new stake in Cigna Group in the 1st quarter worth about $727,905,000. Price T Rowe Associates Inc. MD increased its stake in Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after buying an additional 1,094,327 shares in the last quarter. GQG Partners LLC raised its holdings in shares of Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in shares of Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after acquiring an additional 457,052 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on CI shares. TD Cowen raised Cigna Group to a “strong-buy” rating in a research note on Monday, June 23rd. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a research note on Thursday, August 14th. Wells Fargo & Company upped their price objective on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Royal Bank Of Canada reissued an “outperform” rating and issued a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Finally, Truist Financial set a $375.00 price target on Cigna Group in a research report on Tuesday, September 2nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $369.89.

Cigna Group Stock Performance

NYSE:CI opened at $307.03 on Tuesday. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $350.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a 50 day moving average price of $297.87 and a 200 day moving average price of $307.81. The stock has a market capitalization of $81.96 billion, a P/E ratio of 16.76, a PEG ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same period in the prior year, the firm earned $6.72 earnings per share. The firm’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Insider Activity

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.